Introduction
Protein disulfide isomerase A3 (PDIA3), also known as endoplasmic reticulum protein 57 (ERp57), is a major member of the protein disulfide isomerase (PDI) family. The PDI gene family includes 21 genes that also belong to the thioredoxin (TRX) superfamily. In the perspective of structural evolution, each PDI family member contains a TRX-like domain that can exist in the catalytically active or inactive form [1] . PDI proteins with active TRX-domains commonly reside in the endoplasmic reticulum (ER), where they mediate important thiol-disulfide interchanges during post-translational protein folding [2] . Unlike other PDI family members, PDIA3 is found not only in the ER but also in other intracellular locations. In addition, PDIA3 has no C-terminal ER retention motif that can effectively limit its localization to the ER lumen, which is included in most of the other PDI family members [3, 4] . Although PDIA3 is ubiquitous in the organ system, its physiological activity varies in other tissues. Downregulation of PDIA3 is involved in a variety of pathologies, including cancer [5−7] , airway inflammation [8] , neurodegenerative diseases [9−11] , metabolic diseases [12−14] , and musculoskeletal conditions [15−17] . Furthermore, the expression level of PDIA3 has been evaluated as a useful biomarker for the diagnosis and prognosis of various conditions [5, 18, 19] .
PDIA3 is a multifunctional protein involved in numerous physiological processes and disease states. The unique structure of PDIA3 and its specific expression patterns in ubiquitous, yet diverse tissues contribute to the complexity of its physiological functions. Thus, this protein may be responsible for a variety of diseases via structural or regulatory modifications. Despite significant research effort, the mechanism of action of PDIA3 in many of the above-mentioned pathological conditions is not completely understood. Therefore, the underlying mechanism(s) should be determined and a wide range of treatment approaches that target PDIA3 should be developed. In this context, strategies for the soluble expression and high yield purification of the PDIA3 protein are urgently required to enable a wide application for basic research described above.
In the present study, we developed a systematic approach for the soluble expression of recombinant PDIA3 (rPDIA3), and established a subsequent step for the high yield purification of this protein using Escherichia coli as a host.
Materials and Methods

Bacterial strains and plasmids
The plasmid pHR-1/PDIA3 was used as a template for PCR to amplify the human disulfide isomerase family A member 3 (PDIA3, Accession No. BC014433) cDNA. Another commercially available Bacterial strains and plasmids used in this work were summarized in Table 1 .
Construction and screening of elongation mutant library
All DNAs for the construction of elongation mutant library were prepared and manipulated according to the general methods. The synthetic primers used in this study are listed in Table 2 . A recombinant vector pTrcR was generated by incorporating a ribosome binding sequence (RBS) from pQE30 into pTrc99a. A DNA fragment corresponding to the RBS of pQE30 was amplified by PCR using primers 99ARBS F and 99ARBS R (containing an RBS), followed by digestion with EcoRV and EcoRI. The resulting DNA was cloned into pTrc99a digested with the same restriction enzymes. For the construction of pTrcRR, DNA encoding mCherry was amplified by PCR, with primers mCherry F and R using a Phusion DNA polymerase (New England Biolabs, USA). The amplified DNA was digested with EcoRI and HindIII, and ligated into vector pTrcR digested with the same enzymes.
Elongation mutant pools of the gene encoding PDIA3 were prepared using elongation mutagenesis PCR [20] with a designed N-terminal primer (A3F) containing 3 to 13 amino acids with wobble sequences and fixed C-terminal primer (A3R). The resulting genes were purified using a clean up system (Promega, USA) and cloned into the digested recombinant vector pTrcRR using an Infusion HD cloning kit (Takara, Japan). Then, E. coli was transformed with the elongation mutant library. The resulting cells were grown on LB agar plates without an inducer, and positive clones emitting red fluorescence were screened by direct observation under daylight conditions. These clones were further subjected to protein expression analysis using SDS-PAGE (1.2%) according to general protocols. As a control, a clone harboring the wild-type PDIA3 was prepared by PCR using a set of primers (A3NC and A3R) and analyzed under the same condition. The elongated amino acid residues of the mutant enzymes were analyzed using DNA sequencing.
Analyses of expression patterns and subcloning of the mutant gene for purification
To compare the expression patterns of the mutant proteins with the wild-type protein under the same conditions, the screened mutant proteins were re-subcloned into the plasmid pTrcR without the fused reporter mCherry, according to the same procedure above. A single colony harboring a recombinant plasmid with a control or mutant gene grown on LB agar medium supplemented with 100 μg/ml ampicillin was seeded into LB broth (4 ml) and grown at 37℃ with constant shaking (200 ×g). After overnight incubation, the resulting culture was inoculated (1%, v/v) into 10 ml of LB broth and incubated at 37℃. When the optical density of the culture at 600 nm (OD 600 ) reached approximately 0.5−0.6, isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 mM and further grown for 3 h. The cells from the culture broth were harvested by centrifugation at 8000 ×g and 4℃, resuspended in 200 μl of 50 mM Tris-HCl (pH 8.0), and lysed by sonication for 30 s at 4℃. After cell lysis, insoluble aggregates were removed by centrifugation at 14,000 ×g for 20 min. The resulting pellet and supernatant were analyzed for insoluble and soluble ratio of the expressed protein, respectively. Aliquots of each fraction were mixed with SDS sample loading buffer (0.225 M Tris-HCl pH 6.8, 50% glycerol, 5% SDS, 0.005% bromophenol blue, and 0.25 M DTT) at a ratio of 1:5, boiled for 15 min, and resolved by SDS-PAGE (10%). After electrophoresis, gels were stained with Coomassie blue staining solution.
The cDNA encoding the candidate for protein purification was subcloned into the expression vector pET24a, and expressed under the control of T7 promoter by IPTG induction. To do this, a forward (5'-TAAGAAGGAGA-TATACATATGCCGTCACCGTCAGGG-3') and a reverse (5'-CTCGAGTGCGGCCGCGAGATCCTCCTGTGCCT TCTT-3') primer were used to amplify the cDNA from the recombinant plasmid. The amplified fragment was subcloned into the vector pET24a by homologous recombination, according to the procedure described above. The resulting plasmid was transformed into the host E. coli BL21 (DE3).
Cell culture and expression of the rPDIA3
To purify rPDIA3, the recombinant cells were cultured at 37℃ for 16 h with constant shaking (180 ×g) in 5 ml of Luria-Bertani (LB) medium supplemented with 25 μg/ ml kanamycin (Sigma-Aldrich, USA), as a seed for the main culture. The cultured cells were inoculated (1%, v/v) into 2 L (500 ml × 4) of LB broth and incubated at 37℃ with constant shaking (180 rpm). When the OD 600 reached approximately 0.5−0.6, the IPTG was added to a final concentration of 0.1 mM and the cells were further grown for an additional 16 h at 18℃ with constant shaking (180 ×g). The cells were harvested by centrifugation at 20,000 ×g and 4℃ for 20 min, resuspended in binding buffer (20 ml/g cells; 50 mM Tris, 0.5 M NaCl, 5% glycerol, pH 8.0), and lysed by sonication for 30 min at 4℃. After cell lysis, insoluble aggregates were removed by centrifugation at 20,000 ×g for 20 min. The intensity of rPDIA3 was determined with stained protein bands using the ImageJ program(http://imagej.nih.gov/ij).
Immobilized-metal affinity chromatography (IMAC)
IMAC was used to purify the expressed soluble R1-PDIA3 using HisTrap TM HP (5 ml) column (GE Health- column equilibrated with three column volumes (CVs) of the binding buffer (50 mM Tris, 0.5 M NaCl, 5% glycerol, pH 8.0) at a flow rate of 3 ml/min. The column was washed with seven CVs of washing buffer (20 mM Tris, 0.5 M NaCl, 5% glycerol, 100 mM imidazole, pH 8.0) at a flow rate of 3 ml/min. The bound proteins were eluted with five CVs of elution buffer (20 mM Tris, 0.5 M NaCl, 5% glycerol, 1 M imidazole, pH 8.0) at a flow rate of 3 ml/ min. The eluted solutions were collected in 1.5 ml fraction tubes.
Preparative high-performance liquid chromatography (prep-HPLC)
The IMAC fractions were further purified by reverse phase prep-HPLC. Prep-HPLC was carried out using the Agilent 1200 system (Santa Clara, USA) equipped with a C8 prep HT column (21.2 mm × 150 mm, particle size 5 μm, Agilent Technologies). Solution A was prepared with 0.1% trifluoroacetic acid (TFA) in deionized water and solution B was prepared with 0.09% TFA in acetonitrile (ACN). The column was equilibrated with 10 CVs of solution A at a flow rate of 5 ml/min and loaded with the pooled sample at a flow rate of 1 ml/min. After washing with five CVs of solution A at a flow rate of 5 ml/min followed by washing with 30% solution B at a flow rate of 5 ml/min for 20 min, the bound proteins were eluted with 10 CVs solution A and B at a flow rate of 5 ml/min by the application of linear gradient (30-60% solution B). During the prep-HPLC performance, the solution was monitored at 214 nm and each peak was recorded. The purity of R1-PDIA3 was determined with stained protein bands using the ImageJ program (http:// imagej.nih.gov/ij).
Identification of proteins by MALDI-TOF/TOF
The identification of purified R1-PDIA3 was commissioned to Genomine (Korea). Briefly, gel pieces containing R1-PDIA3 were washed with 50% acetonitrile to remove SDS, salt, and stain. Washed and dehydrated spots were then vacuum dried to remove the solvent and rehydrated with trypsin (8−10 ng/μl) solution in 50 mM ammonium bicarbonate pH 8.7 and incubated 8−10 h at 37℃.
Samples were analyzed using the BRUKER AUTOF-LEX SPEED with LIFT TM (USA) ion optics. Both MS and MS/MS data were acquired with a SMARTBEAM LASER (BRUKER, USA) with 2 kHz repetition rate, and up to 4000 shots were accumulated for each spectrum. MS/MS mode was operated with 2 keV collision energy; the air was used as the collision gas such that nominally single collision conditions were achieved. Although the precursor selection has a possible resolution of 200, in these studies of known single component analytes a resolution of 100 was utilized. Both MS and MS/MS data were acquired using the instrument default calibration, without applying internal or external calibration. MS/MS ions searches were performed with the license Mascot (Matrix Science Ltd., UK) for in-house use.
Results and Discussion
Screening and sequence analysis of recombinant proteins with enhanced solubility Generally, the sequence of amino acids present at the N-terminal region of the protein is an important factor that affects protein expression, localization, and folding. N-terminal sequences are known to play an important role in the interaction with chaperones and the recruitment of ribosomes in the initial stages of expression [21, 22] . These sequences can function as a signature for translational rate control. They are closely linked with the expression level and solubility of proteins. Therefore, in the present study, we devised a strategy to add random oligopeptides at the N-terminus to improve the expression-properties of the proteins of interest [20] .
PDIA3, which catalyzes the formation and cleavage of disulfide bonds, is known as a protein that is difficult to express. We also preliminary attempted to express the target protein by using various vectors and hosts according to general approaches well known. However, it could not be properly expressed in these systems under normal conditions. Although a case showed a distinct band in SDS-PAGE, the resulting protein was highly unstable and unable to satisfy the necessary precondition for further experiment during the purification. Thus, we decided to induce functional overexpression of PDIA3 by elongation mutagenesis at its N-terminus. To achieve this goal, we designed synthetic primers to randomly add certain amino acids that would not form a secondary structure, to avoid modifying the structure of PDIA3 when elongating the N-terminus. PCR-based elongation mutagenesis was performed and the resulting pool was screened for mutants with improved expression and solubility, based on the emitted fluorescence of the fused reporter mCherry. In this procedure, we arbitrarily enriched histidine codons in the wobble sequence to avoid proteolysis and to facilitate protein purification via metal-affinity column, based on a recent report [23] .
A mutant library of >12,000 clones was generated. The prepared library was cultured on LB agar plates for 24−48 h, and red fluorescent clones, which produced higher fluorescence intensity than the wild-type, were selected as the candidates for further analyses. Among these clones, three mutants (R1-PDIA3, R2-PDIA3, R3-PDIA3), which showed distinct fluorescence were finally selected by re-streaking of isolated colonies and from the retransformation results of isolated vectors from the primarily screened clones. SDS-PAGE also revealed that despite being fused to mCherry at their C-termini, these mutant proteins showed increased expression and better solubility (data not shown). Sequence analysis of each mutant construct showed that these variants were elongated by 12 amino acids residues compared with the Nterminus of the wild-type protein ( Table 3) . As expected, prediction using the RBS library calculator (https: //salis.psu.edu/)) [24] showed that elongation by adding an oligopeptide induced a change in the translation initiation rate (TIR). These results suggested that mutagenesis of only terminal regions could effect on the translation rate properties of difficult-to-express proteins [25] . In addition, the resulting bias in the length and sequence of the selected mutants strongly supported the view that histidine-enriched oligopeptide sequences in the N-terminal region of recombinant proteins in E. coli favor a relatively high expression level and solubility, as observed in our previous report [23] . As expected, the elongated peptides at their N-terminal regions were not predicted to form a distinct secondary structure. We re-cloned the selected mutants into pTrcR to exclude the positive effect of the C-terminally fused reporter protein mCherry, and re-analyzed their expression properties.
Analysis and optimization of expression level of rPDIA3
In a preliminary experiment, we observed that the expression levels of the mutant proteins with and without the reporter protein mCherry at the C-terminus were slightly different (data not shown) [26] . As shown in Fig. 1 , the total expression level of R1, R2, and R3-PDAI3 was about 1.5 fold higher than that of the wildtype protein at 37℃ under normal induction conditions. The amount of the recombinant protein in the soluble fractions of three clones was also higher (17−36%) than 45 kDa. The abnormal expression of proteins and stressful explosive induction triggers various stress responses, including the induction of stress responsive proteins, such as the heat shock responsive proteins, in E. coli [27, 28] . We also monitored similar phenomena in repeat culture and/or during the purification of expressed proteins. Thus, further attempts to optimize the expression conditions were conducted in terms of inducer concentration (0.05−1 mM), culture temperate (18−37℃) and time (12− 24 h ). These culture parameters were evaluated under a combination of parameter condition to maximize the enhancement of solubility. All experiments were performed in a 2 L culture with a final volume of 500 ml. The seed culture of all experiments were prepared at 25℃ for overnight prior to adding into the main culture. The solubility and expression level of proteins were monitored by using SDS-PAGE as a function of time. As a result, the main culture conditions were changed to 0.1 mM IPTG, 18℃, 180 ×g, and 16 h. In addition, we selected R1-PDIA3 for further experiments because it showed the best expression level among the three clones (Fig. S1 ). We further attempted to improve the expression level and stability of the recombinant protein R1-PDIA3 using the T7 promoter and a protease negative host system BL21 (DE3). Unexpectedly, the expression level did not increase in this expression system. However, the long-term in-vivo stability was partly improved, which provided more reproducible results for R1-PDIA3's expression-properties. Thus, we used this clone for further protein purification experiments. The selected clone was fermented in 2 L of LB broth, in four 1 L flasks containing a working volume of 500 ml. The SDS-PAGE results showed that all four cultured cells expressed R1-PDIA3 after IPTG induction (Fig. 2A) . The calculated molecular mass of R1-PDIA3 is about 58 kDa, and the corresponding band was observed on SDS-PAGE. Moreover, the expressed R1-PDIA3 was soluble and not aggregated (Fig. 2B) . The cultured cells were collected by centrifugation followed by lysing with sonication. Then, we performed further steps to increase the purity of R1-PDIA3.
Purification and Identification of R1-PDIA3
Separation of the histidine-enriched elongated pep- tide, tagged R1-PDIA3, was performed using an affinity column containing an Ni 2+ complex, a method that is easily applicable to many protein expression systems [29, 30] . Therefore, we adopted the popular IMAC technique as the first purification process of R1-PDIA3. SDS-PAGE analysis showed that R1-PDIA3 was specifically bound and eluted from the column (Fig. 3) , whereas most of the impurities flowed through the affinity column during the loading and washing steps. However, a major protein band corresponding to a molecular weight of about 30 kDa was still mixed with target protein (Fig.  3B) . We carried out an additional purification step using reverse-phase chromatography to increase the purity of R1-PDIA3. The pooled fractions from affinity chromatography containing R1-PDIA3 were subjected to prep-HPLC (Fig. 4A ). As shown in the Fig. 5B , the highest peak (fraction 4 and 5) contained the main impurity (the 30 kDa protein), and fraction 7 contained R1-PDIA3. The purity of the purified R1-PDIA3 was approximately 97.8%, as determined by ImageJ program (Fig. 4C) . To identify the obtained product, the purified R1-PDIA3, we analyzed it by Matrix-assisted laser desorption/ionization Time-of-Flight Mass Spectrometry (MALDI-TOF/ MS). According to the result, we confirmed that the purified R1-PDIA3 was the same as the original one (Fig.  S2) . The purpose of this study was to establish a process for expressing soluble R1-PDIA3 at high purity. Consequently, we obtained soluble and homogenous R1-PDIA3 with an elongated peptide tag through two chromatography steps (His-tag affinity and reverse-phase chromatography). The strategy of elongation mutagenesis with an intentionally enriched sequence of histidine at the N-terminus of a target protein proves to be a valuable tool in improving the expression and purification of proteins that are difficult to express. However, further optimization and more examples using diverse target proteins are needed to validate its technical potential. To broaden the application field, the resulting tag can also be removed simply from the target protein when needed. For example, introducing a specific cleavage site for a protease into a designed primer.
